GENZYME CORP Costs and Expenses
GENZYME CORP reported Costs and Expenses of $4.01 billion for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2011-03-01
- GENZYME CORP costs and expenses for the quarter ending 2010-12-31 was $1.04B, a 8.71% increase year-over-year.
- GENZYME CORP costs and expenses for the quarter ending 2010-09-30 was $912.83M, a 0.30% decline year-over-year.
- GENZYME CORP costs and expenses for the quarter ending 2010-06-30 was $1.07B, a 8.70% increase year-over-year.
- GENZYME CORP costs and expenses for the quarter ending 2010-03-31 was $1.25B, a 42.71% increase year-over-year.
- GENZYME CORP costs and expenses for fiscal 2010 was $4.01B, a 15.72% increase from fiscal 2009.
- GENZYME CORP costs and expenses for fiscal 2009 was $3.47B, a 1.95% decline from fiscal 2008.
- GENZYME CORP costs and expenses for fiscal 2008 was $3.54B.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2010-12-31 | $1.04B derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $1.96B derived: sum of 2 quarters · filed 2011-03-01 | $3.03B derived: sum of 3 quarters · filed 2011-03-01 | $4.01B 10-K · filed 2011-03-01 | |||
| 2010-09-30 | $912.83M 10-Q · filed 2010-11-09 | $1.99B derived: sum of 2 quarters · filed 2010-11-09 | $2.97B 10-Q · filed 2010-11-09 | $4.20B derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2010-06-30 | $1.07B 10-Q/A · filed 2010-09-07 | $2.33B 10-Q/A · filed 2010-09-07 | $3.29B derived: sum of 3 quarters · filed 2011-03-01 | $4.20B derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2010-03-31 | $1.25B 10-Q/A · filed 2010-05-11 | $2.21B derived: sum of 2 quarters · filed 2011-03-01 | $3.13B derived: sum of 3 quarters · filed 2011-03-01 | $4.12B derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2009-12-31 | $959.96M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $1.88B derived: sum of 2 quarters · filed 2011-03-01 | $2.86B derived: sum of 3 quarters · filed 2011-03-01 | $3.47B 10-K · filed 2011-03-01 | $4.01B 10-K · filed 2010-03-01 | ||
| 2009-09-30 | $915.60M 10-Q · filed 2010-11-09 | $1.05B 10-Q · filed 2009-11-02 | $1.90B derived: sum of 2 quarters · filed 2010-11-09 | $2.51B 10-Q · filed 2010-11-09 | $2.91B 10-Q · filed 2009-11-02 | $3.35B derived: sum of 4 quarters · filed 2011-03-01 | |
| 2009-06-30 | $988.21M 10-Q/A · filed 2010-09-07 | $1.87B 10-Q/A · filed 2010-09-07 | $2.43B derived: sum of 3 quarters · filed 2011-03-01 | $3.41B derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2009-03-31 | $878.30M 10-Q/A · filed 2010-05-11 | $1.44B derived: sum of 2 quarters · filed 2011-03-01 | $2.42B derived: sum of 3 quarters · filed 2011-03-01 | $3.51B derived: sum of 4 quarters · filed 2011-03-01 | |||
| 2008-12-31 | $565.64M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $1.54B derived: sum of 2 quarters · filed 2011-03-01 | $2.63B derived: sum of 3 quarters · filed 2011-03-01 | $3.54B 10-K · filed 2011-03-01 | $4.02B 10-K · filed 2010-03-01 | ||
| 2008-09-30 | $976.91M 10-Q · filed 2009-11-02 | $2.06B derived: sum of 2 quarters · filed 2009-11-02 | $2.97B 10-Q · filed 2009-11-02 | ||||
| 2008-06-30 | $1.09B 10-Q/A · filed 2009-09-04 | $1.99B 10-Q/A · filed 2009-09-04 | |||||
| 2007-12-31 | $3.16B 8-K · filed 2010-06-14 |